Newsletter | August 31, 2026

08.31.26 -- Reshaping Inhalation, Injectables & Combination Products

SPONSOR

 

 

Discovery & Development US 2026 puts your brand in front of thousands of biopharma decision-makers. 52% from pharma and biotech, 60% actively budgeted for new solutions. Through immersive sponsorship formats, guaranteed 1:1 meetings with pre-qualified buyers, audience engagement data, and tailored media coverage, it's a platform built to accelerate your pipeline conversations and visibility in one place.

FEATURED EDITORIAL

Weighing The Why And How Of Inhalation Delivery Innovation

Chief Editor Tom von Gunden discusses opportunities and challenges for advancing inhalation delivery, including aspects such as particle engineering, device usability, and ecosystem coordination across inhalation design, development, and distribution. The coverage of technology innovations includes inhalers, nebulizers, and nasal sprays. 

 

Advanced Polymers For Depot-Based Long-Acting Injectables

PLGA-based long-acting injectables drive sustained drug delivery, with advances in generics, depot technologies, and manufacturing expanding patient access and innovation.

INDUSTRY INSIGHTS

 

When Drug Delivery Becomes A Combination Product

As eye drop therapies face stricter combination product regulations, developers must adapt strategies for compliance and commercialization

 

Patient-Centric Formulations In Pediatric Adherence

Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory insights help overcome barriers and support safer therapies for children.

 

Solving Formulation Challenges Across Modalities

Optimize drug delivery by leveraging advanced nanoparticle engineering to dramatically increase small-molecule oral drug loading and enable ultra-high-concentration subcutaneous formulations.

 

Selecting A CDMO For Custom Activated PEGs

Custom-activated PEGs require thoughtful planning and precise analytical control. Discover key considerations for selecting a partner capable of supporting scalable, compliant PEGylation.

 

Selecting A Prefillable Syringe System With Confidence

Prefilled syringe selection can stall drug development for months. This system integrates barrel, plunger, and needle shield from a single supplier, reducing complexity for emerging biotech.

 

Modular VFlexible Aseptic Filling Lines

Modular suites with built-in contamination control streamline sterile manufacturing—supporting complex products, faster timelines, greater flexibility, less disruption, and scalable fill‑finish.

SOLUTIONS

Pharma Services Fill, Finish & Drug Delivery CDMO